Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Safety of BMN 333 versus Vosoritide in Children with Achondroplasia'. The following are the other relevant details related to the trial:
Therapeutic Area: Paediatrics
Trial Centre(s):
KK Women's & Children's Hospital
Trial Status: NA
Principal Investigator(s):
Dr Goh Lay Kuan Jeannette
Published by HT Digital Content Services with permission from Health Daily Digest....